Link to this page
Ontology of Drug Adverse Events
Last uploaded:
January 12, 2019
Jump to:
| Id | http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000007133
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000007133
|
|---|---|
| Preferred Name | Erythromycin [Chemical/Ingredient] |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label |
Erythromycin [Chemical/Ingredient]
|
|---|---|
| prefLabel |
Erythromycin [Chemical/Ingredient]
|
| NUI |
N0000007133
|
| Synonym |
Erythromycin A
|
| code |
C24618
|
| prefixIRI |
NDF-RT:N0000007133
|
| RxNorm_CUI |
4053
|
| subClassOf | |
| imported from | |
| MeSH_CUI |
M0007715
|
| MeSH_DUI |
D004917
|
| type | |
| MeSH_Name |
Erythromycin
|
| UMLS_CUI |
C0014806
|
| RxNorm_Name |
Erythromycin
|
| Display_Name |
Erythromycin
|
| MeSH_Definition |
A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |